E. Batiste-Alentorn

676 total citations
11 papers, 468 citations indexed

About

E. Batiste-Alentorn is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E. Batiste-Alentorn has authored 11 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Batiste-Alentorn's work include Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). E. Batiste-Alentorn is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Gastric Cancer Management and Outcomes (4 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). E. Batiste-Alentorn collaborates with scholars based in Spain. E. Batiste-Alentorn's co-authors include Àngels Arcusa, Francisco Rodríguez‐Moranta, Jaume Boadas, Antoni Castells, Salvadora Delgado, Josep M. Piqué, Joan Saló, Xavier Bessa, Virgı́nia Piñol and Joan Maurel and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

E. Batiste-Alentorn

11 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Batiste-Alentorn Spain 6 265 216 170 81 49 11 468
Raul Cutait Brazil 10 290 1.1× 260 1.2× 113 0.7× 96 1.2× 33 0.7× 35 454
D Jackson United States 9 197 0.7× 264 1.2× 307 1.8× 71 0.9× 69 1.4× 12 502
Masaki Kashiwazaki Japan 10 145 0.5× 154 0.7× 100 0.6× 31 0.4× 22 0.4× 42 309
F Latteri Italy 7 211 0.8× 184 0.9× 236 1.4× 15 0.2× 57 1.2× 27 421
Davide Di Mauro Italy 9 434 1.6× 337 1.6× 160 0.9× 116 1.4× 37 0.8× 30 570
W. A. Bemelman Netherlands 11 173 0.7× 453 2.1× 81 0.5× 26 0.3× 25 0.5× 29 608
Masahiro Kanno Japan 12 99 0.4× 188 0.9× 132 0.8× 32 0.4× 9 0.2× 50 340
Kyo-Sang Yoo South Korea 13 251 0.9× 326 1.5× 223 1.3× 16 0.2× 26 0.5× 18 475
Takeshi Tomiyama Japan 14 215 0.8× 544 2.5× 414 2.4× 33 0.4× 28 0.6× 39 629
Okihide Suzuki Japan 9 100 0.4× 110 0.5× 178 1.0× 126 1.6× 85 1.7× 45 338

Countries citing papers authored by E. Batiste-Alentorn

Since Specialization
Citations

This map shows the geographic impact of E. Batiste-Alentorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Batiste-Alentorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Batiste-Alentorn more than expected).

Fields of papers citing papers by E. Batiste-Alentorn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Batiste-Alentorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Batiste-Alentorn. The network helps show where E. Batiste-Alentorn may publish in the future.

Co-authorship network of co-authors of E. Batiste-Alentorn

This figure shows the co-authorship network connecting the top 25 collaborators of E. Batiste-Alentorn. A scholar is included among the top collaborators of E. Batiste-Alentorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Batiste-Alentorn. E. Batiste-Alentorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Roura‐Poch, Pere, et al.. (2023). Trend and Joinpoint Analysis of Cancer Incidence and 1-Year Mortality in North-East Spain 2005–2020. Cancers. 15(23). 5527–5527. 2 indexed citations
2.
Salud, Antonieta, E. Batiste-Alentorn, Eugeni Saigí, et al.. (2005). Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer. European Journal of Cancer. 41(15). 2241–2249. 9 indexed citations
3.
Saigí, Eugeni, E. Batiste-Alentorn, António Galán de Mera, et al.. (2005). Phase II study of weekly irinotecan (CPT-11) associated to protracted oral tegafur (TGF) in previously untreated, advanced colorectal cancer (ACRC). Journal of Clinical Oncology. 23(16_suppl). 3725–3725. 1 indexed citations
4.
Rodríguez‐Moranta, Francisco, Joan Saló, Àngels Arcusa, et al.. (2005). Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, Randomized, Controlled Trial. Journal of Clinical Oncology. 24(3). 386–393. 197 indexed citations
5.
6.
Salud, Antonieta, E. Batiste-Alentorn, Ferrán Losa, et al.. (2004). Randomized phase IV trial of oral tegafur and low dose leucovorin versus intravenous 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer (ACC): Final results. Journal of Clinical Oncology. 22(14_suppl). 3547–3547. 4 indexed citations
7.
Muro, Xavier García del, Pablo Maroto, A. Barnadas, et al.. (2003). 884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience. European Journal of Cancer Supplements. 1(5). S266–S266. 1 indexed citations
8.
Cirera, Lluís, Àngels Arcusa, E. Batiste-Alentorn, et al.. (2002). Phase II study of gemcitabine and cisplatin in chemonaive patients with advanced epithelial ovarian cancer. Anti-Cancer Drugs. 13(8). 839–845. 21 indexed citations
9.
Bellmunt, Joaquim, Vicente Guillém, Luis Paz‐Ares, et al.. (2000). Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium. Journal of Clinical Oncology. 18(18). 3247–3255. 134 indexed citations
10.
Cirera, Luis, A. Balil, E. Batiste-Alentorn, et al.. (1999). Randomized Clinical Trial of Adjuvant Mitomycin Plus Tegafur in Patients With Resected Stage III Gastric Cancer. Journal of Clinical Oncology. 17(12). 3810–3815. 88 indexed citations
11.
Beltrán, Miguel, María C. Alonso, Á. Izquierdo, et al.. (1991). Alternating sequential endocrine therapy: Tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients. Annals of Oncology. 2(7). 495–499. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raul Cutait Breakdown of academic impact, for papers by D Jackson Breakdown of academic impact, for papers by Masaki Kashiwazaki Breakdown of academic impact, for papers by F Latteri Breakdown of academic impact, for papers by Davide Di Mauro Breakdown of academic impact, for papers by W. A. Bemelman Breakdown of academic impact, for papers by Masahiro Kanno Breakdown of academic impact, for papers by Kyo-Sang Yoo Breakdown of academic impact, for papers by Takeshi Tomiyama Breakdown of academic impact, for papers by Okihide Suzuki
Rankless by CCL
2026